Diagnosis and clinical features of pemphigus foliaceus

Dermatologic Clinics

Volumn 29, Issue 3, 2011, Pages 405-412

  James, Kirk A ^a   Culton, Donna A ^a   Diaz, Luis A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Desmoglein 1; Diagnosis; Endemic; Fogo selvagem; History; Pemphigus foliaceus

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; BUCILLAMINE; CANDESARTAN; CAPTOPRIL; DESMOGLEIN 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ENALAPRIL; FOSINOPRIL; IMMUNOGLOBULIN G; LISINOPRIL; ORPHAN DRUG; PENICILLAMINE; RIFAMPICIN; TIOPRONIN;

ACANTHOLYSIS; AGE DISTRIBUTION; ANTIBODY PRODUCTION; AUTOIMMUNE SKIN DISEASE; BLISTER; BULLOUS SKIN DISEASE; CELL JUNCTION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EPIDERMIS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; KERATINOCYTE; MEDICAL HISTORY; PEMPHIGUS FOLIACEUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN BIOPSY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; PEMPHIGUS; PREVALENCE; SKIN;

EID: 79956258326     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.03.012     Document Type: Review

References (82)

1. Rock B., Martins C.R., Theofilopoulos A.N., et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med 1989, 320:1463-1469.
2. Sekiguchi M., Futei Y., Fujii Y. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 2001, 167:5439-5448.
3. Li N., Aoki V., Hans-Filho G., et al. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003, 197:1501-1510.
4. Rubenstein D.S., Diaz L.A. Pemphigus antibody induced phosphorylation of keratinocyte proteins. Autoimmunity 2006, 39:577-586.
5. Berkowitz P., Chua M., Liu Z., et al. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol 2008, 173:1628-1636.
6. Lee H.E., Berkowitz P., Jolly P.S., et al. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. J Biol Chem 2009, 284:12524-12532.
7. España A., Diaz L.A., Mascaró J.M. Mechanisms of acantholysis in pemphigus foliaceus. Clin Immunol Immunopathol 1997, 85:83-89.
8. Robinson N.D., Hashimoto T., Amagai M., et al. The new pemphigus variants. J Am Acad Dermatol 1999, 40:649-671.
9. Bastuji-Garin S., Souissi R., Blum L., et al. Comparative epidemiology of pemphigus in Tunisia and France unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 1995, 104:302-305.
10. Culton D.A., Qian Y., Li N., et al. Advances in pemphigus and its endemic pemphigus foliaceus. J Autoimmun 2008, 31:311-324.
11. Warren S.J., Lin M.S., Giudice G.J., et al. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med 2000, 343:23-30.
12. Abreu-Velez A.M., Hashimoto T., Bollag W.B., et al. A unique form of endemic pemphigus in northern Colombia. J Am Acad Dermatol 2003, 49:599-608.
13. Robledo M.A., Prada S., Jaramillo D., et al. South American pemphigus foliaceus: study of an epidemic in El Bagre and Nechi, Colombia 1982 to 1986. Br J Dermatol 1988, 118:737-744.
14. Meyer N., Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010, 9:A379-A382.
15. Penas P.F., Buezo G.F., Carvajal I., et al. D-Penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol 1997, 37:121-123.
16. Brenner S., Bialy-Golan A., Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998, 16:393-397.
17. Perry H.O., Brunsting L.A. Pemphigus foliacaeus. Further observations. Arch Dermatol 1965, 91:10-23.
18. Cram D.L., Winkelmann R.K. Ultraviolet-induced acantholysis in pemphigus. Arch Dermatol 1965, 92:7-13.
19. Aghassi D., Dover J.S. Pemphigus foliaceus induced by psoralen-UV-A. Arch Dermatol 1998, 134:1300-1301.
20. Low G.J., Keeling J.H. Ionizing radiation-induced pemphigus. Case presentations and literature review. Arch Dermatol 1990, 126:1319-1323.
21. Kaplan R.P., Potter T.S., Fox J.N. Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 1992, 26:364-366.
22. Patterson C.R., Davies M.G. Pemphigus foliaceus: an adverse reaction to lisinopril. J Dermatolog Treat 2004, 15:60-62.
23. Shelton R.M. Pemphigus foliaceus associated with enalapril. J Am Acad Dermatol 1991, 24:503-504.
24. Ong C.S., Cook N., Lee S. Drug-related pemphigus and angiotensin converting enzyme inhibitors. Australas J Dermatol 2000, 41:242-246.
25. Fujita H., Iguchi M., Watanabe R., et al. Pemphigus foliaceus induced by bucillamine. Eur J Dermatol 2007, 17:98-99.
26. Bae Y.I., Yun S.J., Lee S.C., et al. Pemphigus foliaceus induced by an angiotensin II receptor blocker. Clin Exp Dermatol 2008, 33:721-723.
27. Lee C.W., Lim J.H., Kang H.J. Pemphigus foliaceus induced by rifampicin. Br J Dermatol 1984, 111:619-622.
28. Lucky P.A., Skovby F., Thier S.O. Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine. J Am Acad Dermatol 1983, 8:667-672.
29. Korman N.J., Stanley J.R., Woodley D.T. Coexistence of pemphigus foliaceus and bullous pemphigoid. Arch Dermatol 1991, 127:387-390.
30. Ishiko A., Hashimoto T., Shimizu H., et al. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies. Arch Dermatol 1995, 131:732-734.
31. Imamura S., Takigawa M., Ikai K., et al. Pemphigus foliaceus, myasthenia gravis, thymoma and red cell aplasia. Clin Exp Dermatol 1978, 3:285-291.
32. Ng P.P., Ng S.K., Chng H.H. Pemphigus foliaceus and oral lichen planus in a patient with systemic lupus erythematosus and thymoma. Clin Exp Dermatol 1998, 23:181-184.
33. Cowley N.C., Neill S.M., Staughton R.C. Pemphigus foliaceus and non-Hodgkin's lymphoma. Int J Dermatol 1994, 33:510-511.
34. Rybojad M., Leblanc T., Flageul B., et al. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol 1993, 128:418-422.
35. Ota M., Sato-Matsumura K.C., Matsumura T., et al. Pemphigus foliaceus and figurate erythema in a patient with prostate cancer. Br J Dermatol 2000, 142:816-818.
36. Inaoki M., Kaji K., Furuse S., et al. Pemphigus foliaceus developing after metastasis of cutaneous squamous cell carcinoma to regional lymph nodes. J Am Acad Dermatol 2001, 45:767-770.
37. Kawana S., Hashimoto T., Nishikawa T., et al. Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch Dermatol 1994, 130:1534-1538.
38. Tsuji Y., Kawashima T., Yokota K., et al. Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system. Arch Dermatol 2002, 138:95-96.
39. Ishii K., Amagai M., Ohata Y., et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol 2000, 42:859-861.
40. Walker D.C., Kolar K.A., Hebert A.A., et al. Neonatal pemphigus foliaceus. Arch Dermatol 1995, 131:1308-1311.
41. Avalos-Díaz E., Olague-Marchan M., López-Swiderski A., et al. Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus. J Am Acad Dermatol 2000, 43:1130-1134.
42. Hirsch R., Anderson J., Weinberg J.M., et al. Neonatal pemphigus foliaceus. J Am Acad Dermatol 2003, 49:S187-S189.
43. Eyre R.W., Stanley J.R. Maternal pemphigus foliaceus with cell surface antibody bound in neonatal epidermis. Arch Dermatol 1988, 124:25-27.
44. Rocha-Alvarez R., Friedman H., Campbell I.T., et al. Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies. J Invest Dermatol 1992, 99:78-82.
45. Swinburne L.M. Leucocyte antigens and placental sponge. Lancet 1970, 2:592-594.
46. Wu H., Wang Z.H., Yan A., et al. Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med 2000, 343:31-35.
47. Moraes M.E., Fernandez-Vina M., Lazaro A., et al. An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 1997, 49:35-40.
48. Eaton D.P., Diaz L.A., Hans-Filho G., et al. Comparison of black fly species on an American reservation with a high prevalence of fogo selvage to neighboring disease-free sites in the state of Mato Grosso do Sul, Brazil. J Med Entomol 1998, 35:120-131.
49. Ribeiro J.M., Valenzuela J.G., Pham V.M., et al. An insight into the sialotranscriptome of Simulium nigrimanum, a black fly associated with fogo selvagem in South America. Am J Trop Med Hyg 2010, 82:1060-1075.
50. Diaz L.A., Sampaio S.A., Rivitti E.A., et al. Endemic pemphigus foliaceus (fogo selvagem): II current and historic epidemiologic studies. J Invest Dermatol 1989, 92:4-12.
51. Uzun S., Durdu M. The specificity and sensitivity of Nikolsky sign in the diagnosis of pemphigus. J Am Acad Dermatol 2006, 54(3):411-415.
52. Steffen C., Thomas D. The men behind the eponym: Francis E. Senear, Barney Usher, and the Senear-Usher syndrome. Am J Dermatopathol 2003, 25:432-436.
53. Bruckner N., Katz R.A., Hood A.F. Pemphigus foliaceus resembling eruptive seborrheic keratoses. Arch Dermatol 1980, 116:815-816.
54. Kahana M., Trau H., Schewach-Millet M., et al. Pemphigus foliaceus presenting as multiple giant seborrheic keratoses. J Am Acad Dermatol 1984, 11:299-300.
55. Metry D.W., Hebert A.A., Jordon R.E. Nonendemic pemphigus foliaceus in children. J Am Acad Dermatol 2002, 46:419-422.
56. Mutasim D.F., Adams B.B. Immunofluorescence in dermatology. J Am Acad Dermatol 2001, 45:803-822.
57. Kouskoukis C.E., Ackerman A.B. Vacuoles in the upper part of the epidermis as a clue to eventuation of superficial pemphigus and bullous impetigo. Am J Dermatopathol 1984, 6:183-186.
58. Osteen F.B., Wheeler C.E., Briggaman R.A., et al. Pemphigus foliaceus. Early clinical appearance as dermatitis herpetiformis with eosinophilic spongiosis. Arch Dermatol 1976, 112:1148-1152.
59. Kouskoukis C.E., Ackerman A.B. What histologic finding distinguishes superficial pemphigus and bullous impetigo?. Am J Dermatopathol 1984, 6:179-181.
60. Furtado T. Histopathology of pemphigus foliaceus. Arch Dermatol 1959, 80:66.
61. Harrist T.J., Mihm M.C. Cutaneous immunopathology. The diagnostic use of direct and indirect immunofluorescence techniques in diagnostic dermatopathology. Hum Pathol 1979, 10:625.
62. Judd K.P., Lever W.F. Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979, 115:428-432.
63. Rodriguez J., Bystryn J.C. Pemphigus foliaceus associated with absence of intercellular antigens in lower layers of epidermis. Arch Dermatol 1977, 113:1696-1699.
64. Bhogal B., Wojnarowska F., Black M.M., et al. The distribution of immunoglobulins and the C3 component of complement in multiple biopsies from the uninvolved and perilesional skin in pemphigus. Clin Exp Dermatol 1986, 11:49-53.
65. Chorzelski T.P., Jablonska S., Blaszczyk M. Immunopathological investigations in the Senear-Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br J Dermatol 1968, 80:211-217.
66. Feibleman C., Stolzner G., Provost T.T. Pemphigus: superiority of monkey esophagus in the determination of pemphigus antibody. Arch Dermatol 1981, 117:561-562.
67. Shirakata Y., Amagai M., Hanakawa Y., et al. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol 1998, 110:76-78.
68. Harman K.E., Gratian M.J., Bhogal B.S., et al. The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus. Br J Dermatol 2000, 142:1135-1139.
69. Bystryn J.C., Abel F.L., DeFeo D. Pemphigus foliaceus: subcorneal intercellular antibodies of unique specificity. Arch Dermatol 1974, 110:857-861.
70. Futei Y., Amagai M., Ishii K., et al. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci 2001, 26:55-61.
71. Hacker M.K., Janson M., Fairley J.A., et al. Isotypes and antigenic profiles of pemphigus foliaceous and pemphigus vulgaris autoantibodies. Clin Immunol 2002, 105:64-74.
72. Fitzpatrick R.E., Newcomer V.D. The correlation of disease activity and antibody titers in pemphigus. Arch Dermatol 1980, 116:285-290.
73. Anhalt G.J., Labib R.S., Voorhees J.J., et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982, 306:1189-1196.
74. Ishii K., Amagai M., Hall R.P., et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997, 159:2010-2017.
75. Crowther J.R. ELISA. Theory and practice. Methods Mol Biol 1995, 42:1-218.
76. Harman K.E., Gratian M.J., Seed P.T., et al. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000, 25:236-240.
77. Amagai M., Komai A., Hashimoto T., et al. Usefulness of enzyme-linked immunosorbent assay (ELISA) using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999, 140:351-357.
78. Qaqish B.F., Prisayanh P., Qian Y., et al. Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol 2009, 129:110-118.
79. Aoyama Y., Tsujimura Y., Funabashi M., et al. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus. Eur J Dermatol 2000, 10:18-21.
80. Cheng S.W., Kobayashi M., Kinoshita-Kuroda K., et al. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002, 147:261-265.
81. Abasq C., Mouquet H., Gilbert D., et al. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Arch Dermatol 2009, 145:529-535.
82. Schmidt E., Dähnrich C., Rosemann A., et al. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol 2010, 19:458-463.